NIFEXINE, cream rectal tube, 30 g
Active ingredients: Lidocaine hydrochloride, Nifedipine
Commercialized according to BDPMDispensing in France: Prescription only
Creamtube, 30 grectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NIFEXINE, crème rectale
- Pharmaceutical form
- crème
- Route of administration
- rectale
- Presentation description
- 1 tube(s) aluminium de 30 g avec canule endorectale en polyéthylène basse densité (PEBD)
- Marketing authorisation holder
- NEOPHARMED GENTILI (ITALIE)
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63967022CIP73020101CIP133400930201015Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NIFÉDIPINEcrème | 0,30 g · 100 g de crème | SA |
| CHLORHYDRATE DE LIDOCAÏNEcrème | 1,50 g · 100 g de crème | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.